Europe Dialysis Market

Europe Dialysis Market Size (2023 to 2028)

The European market size for dialysis is forecasted to grow at a CAGR of 7.33% from 2023 to 2028 and be worth USD 48.87 billion by 2028 from USD 34.31 billion in 2023.

Factors such as growing patient volume suffering from diabetes and hypertension across the European region, growing funding to conduct R&D for the new product development, and YOY growth in the patient count suffering from end-stage renal disease (ESRD) are propelling the European dialysis market growth. According to the International Diabetes Federation (IDF), an estimated 61 million people aged between 20 to 79 years lived with diabetes in the European region in 2021. Furthermore, according to the Journal of the American Heart Association (AHAjournal), hypertension among the European population is growing considerably. According to Eurostat, an estimated 22% of the European population aged above reported having high BP in 2019.

In addition, the rising number of people with end-stage renal disease (ESRD) will increase demand for CKD treatments, and it is used to treat those who need kidney transplants or long-term renal care because both kidneys have failed. Dialysis is the most preferred treatment option over kidney transplantation, which is estimated to result in the growing usage of dialysis and the increased market’s growth rate in Europe. Furthermore, YOY growth in aging, rising healthcare expenditure, and growing disposable income are estimated to fuel the growth rate of the dialysis market in the European region. Furthermore, the increasing alcohol consumption is resulting in the growing incidence of kidney function loss, which is expected to reflect in the dialysis market growth in the European region.

However, the complications associated with dialysis are key factors hampering the market's growth rate. Furthermore, a lack of awareness regarding renal disorders, a growing number of product recalls, and reductions in dialysis reimbursements are inhibiting the growth rate of the European dialysis market. In addition, alternative renal therapy options, such as kidney transplants, are hindering the growth of the European dialysis market.

This report on the European dialysis market has been segmented and sub-segmented into the following categories.

By Type:

• Products
• Services

Based on type, the services segment is anticipated to hold a major share of the European dialysis market during the forecast period.

On the other hand, the products segment is expected to register a healthy CAGR during the forecast period in the European dialysis market. YOY growth in the number of people undergoing dialysis procedures across the European region is the major factor promoting the segment’s growth rate. In addition, the growing incidence of kidney failure among the European population contributes to the segment's growth. According to the European Kidney Health Alliance (EKHA), an estimated 75 million across the European region have CKD.

By Dialysis Type

• Hemodialysis
• Peritoneal Dialysis

Based on dialysis, the hemodialysis segment had the largest share of the European dialysis market in 2021.

By End-User

• Dialysis Centers & Hospitals
• Home Care 

Based on the end-user, the dialysis centers and hospitals segment is anticipated to hold the largest share of the European dialysis market during the forecast period. The growing preference from people to have dialysis at dialysis centers and the advantages associated with dialysis centers propel the segment’s growth.

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Geographically, Europe had the second most significant share in the global market in 2022 and is expected to grow steadily during the forecast period due to the prevalence of renal damage among patients in Germany and the United Kingdom. Furthermore, the European market is further expected to expand due to an aging population suffering from chronic diseases and organ abnormalities. Furthermore, in developing nations, the availability of highly qualified nephrologists has complemented the expansion of renal care facilities. As a result, investors are pouring money into Germany, Spain, France, and other developing countries to improve renal care facilities, impacting the dialysis market's growth.

In 2022, the German dialysis market held the largest share of the European market and is also expected to showcase a healthy CAGR during the forecast period. YOY growth in the number of patients suffering from ESRD and kidney failures across Germany is one of the potential factors supporting the German dialysis market.

KEY MARKET PLAYERS:

Fresenius Medical Care AG & Co. KGaA, DaVita Healthcare Partners, Inc., B. Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Diaverum Healthcare Partners, Medtronic, Asahi Kasei Corporation, and Nipro Corporation are some of the promising companies operating in the European dialysis market profiled in this report.